electroCore (ECOR) Notes Payables (2019 - 2026)
electroCore (ECOR) recorded quarterly Notes Payables of $250000.0 in Q1 2026, down 54.17% quarter-over-quarter from $545551.0 in Q1 2021.
electroCore (ECOR) Notes Payables (2019 - 2026) Analysis & Trends
electroCore's Notes Payables history runs 4 years deep, the most recent figure standing at $250000.0 for Q1 2026.
- In Q1 2026, Notes Payables changed N/A year-over-year to $250000.0; the TTM figure through Mar 2026 stood at $250000.0 (changed N/A YoY), while the FY2020 annual figure was $311354.0, up 178.3% from the prior year.
- Notes Payables was $250000.0 for Q1 2026 at electroCore, down from $545551.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $250000.0 in Q1 2026 to a low of $250000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | electroCore | 75,742.38 | -8.80 Mn | 8.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 250,000.00 |
| Mar 31, 2021 | 545,551.00 |
| Dec 31, 2020 | 311,354.00 |
| Sep 30, 2020 | 732,305.00 |
| Jun 30, 2020 | 552,410.00 |
| Dec 31, 2019 | 111,878.00 |
| Sep 30, 2019 | 461,341.00 |